Matthew Starr, MD
Ophthalmology · Rochester, MNNPI 1972982262
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,865 of the $16,463 with a category attached, or 78.1%. 9 manufacturers reported payments, led by AbbVie at 49.6% of the total. Reporting peaked in 2023 at $8,217 and has fallen 53.6% since, to $3,815 in 2025. Among ophthalmology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 27 payments — averaging $609.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$8K
- Genentech USA, Inc.$4K
- Genentech, Inc.$2K
- Alcon$1K
- Spark Therapeutics, Inc.$1K
- Dutch Ophthalmic, USA$176
- plus $201 from 3 others
Across 9 payments — averaging $4696.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$42K
- F. Hoffmann-la Roche AG$668
What the payments were for
- Consulting fees$12,86578%
- Travel & lodging$2,22614%
- Food & beverage$1,3728%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 7 | $8,161 |
| Genentech USA, Inc. | 3 | $3,772 |
| Genentech, Inc. | 1 | $1,650 |
| Alcon | 6 | $1,426 |
| Spark Therapeutics, Inc. | 5 | $1,078 |
| Dutch Ophthalmic, USA | 1 | $176 |
| Regeneron Healthcare Solutions, Inc. | 2 | $125 |
| Leica Microsystems Inc. | 1 | $64 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OZURDEX$8,079
- VABYSMO$5,401
- LUXTURNA$909
- DAILIES$499
- EVA, combined machine$176
- TISSUEBLUE$176
- EYLEA$110
How this compares
$16,463 in reported general payments places this provider in the 90th percentile of 330 ophthalmology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 25 | $980 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 16 | $286 |
| Latanoprost | 14 | $188 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Rochester
- Sophie BakriRochester$183K
- John ChenRochester$82K
- Raymond IezziRochester$44K
- Arthur SitRochester$33K
- Muhammad BhattiRochester$24K
- Brittni ScruggsRochester$21K
- Sanjay PatelRochester$20K
- Lilly WagnerRochester$15K
- John WoogRochester$6K
- James GarrityRochester$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.